Vulvar skin disorders throughout lifetime: about some representative dermatoses

Jean Doyen, Stéphanie Demoulin, Katty Delbecque, Frédéric Goffin, Frédéric Kridelka, Philippe Delvenne, Jean Doyen, Stéphanie Demoulin, Katty Delbecque, Frédéric Goffin, Frédéric Kridelka, Philippe Delvenne

Abstract

The objective of this paper is to present general considerations which should be kept in mind by clinicians in charge of women with vulvar diseases. Four representative vulvar dermatoses are described. Lichen simplex chronicus is a pathological condition related to chemical and mechanical irritant agents. Detrimental effects of these irritants, in the presence of other dermatoses, have to be considered when therapeutic responses are unsatisfactory. Lichen sclerosus is the most common vulvar dermatosis in elderly. However, it should be kept in mind that it may be diagnosed at any age. Lichen planus, in spite of sharing a similar range of etiological factors with lichen sclerosus, is a very distinct entity. Finally, Paget's disease, although rare, is also described especially because of the challenge it represents both clinically and therapeutically.

Figures

Figure 1
Figure 1
(a) Irregular white to brown patch on the vulvar skin of a 74-year-old woman. (b) Representative example of a lichen sclerosus biopsy specimen showing a thinned epidermis with slight hyperkeratosis, loss of the rete ridges, and a band of homogenized collagen below the dermoepidermal junction.
Figure 2
Figure 2
(a) Wide vestibular erythematous erosive lichen planus in a 79-year-old woman. (b) Representative example of a lichen planus biopsy specimen showing an irregular hyperkeratosis and a lymphoid dermal infiltrate appearing as a distinct band close to the epidermis.
Figure 3
Figure 3
(a) Wide red area extending mainly on the left side of the vulva in a 65-year-old woman with Paget's disease. (b) Representative example of Paget's disease biopsy specimen showing many glandular neoplastic cells with clear cytoplasm present singly or in small nests within the epidermis.

References

    1. Lynch PJ, Moyal-Barrocco M, Bogliatto F, Micheletti L, Scurry J. 2006 ISSVD classification of vulvar dermatoses: pathologic subsets and their clinical correlates. The Journal of Reproductive Medicine. 2007;52(1):3–9.
    1. Lynch PJ, Moyal-Barracco M, Scurry J, Stockdale C. 2011 ISSVD terminology and classification of vulvar dermatological disorders: an approach to clinical diagnosis. Journal of Lower Genital Tract Disease. 2012;16(4):339–344.
    1. Eva LJ. Screening and follow up of vulval skin disorders. Best Practice & Research Clinical Obstetrics & Gynaecology. 2012;26(2):175–188.
    1. Fistarol SK, Itin PH. Diagnosis and treatment of lichen sclerosus. American Journal of Clinical Dermatology. 2013;14(1):27–47.
    1. del Pino M, Rodriguez-Carunchio L, Ordi J. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma. Histopathology. 2013;62(1):161–175.
    1. Weyers W. Hypertrophic lichen sclerosus with dyskeratosis and parakeratosis—a common presentation of vulvar lichen sclerosus not associated with significant risk of malignancy. The American Journal of Dermatopathology. 2013;35(7):713–721.
    1. Van Seters M, Ten Kate FJW, Van Beurden M, et al. In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiology. Journal of Clinical Pathology. 2007;60(5):504–509.
    1. Goldstein AT, Creasey A, Pfau R, Phillips D, Burrows LJ. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. Journal of the American Academy of Dermatology. 2011;64(6):e99–e104.
    1. Cook BA, Warshaw EM. Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis. American Journal of Clinical Dermatology. 2009;10(2):103–118.
    1. Siegfried EC, Jaworski JC, Hebert AA. Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice. American Journal of Clinical Dermatology. 2013;14(3):163–178.
    1. Simpson RC, Thomas KS, Leighton P, Murphy R. Diagnostic criteria for erosive lichen planus affecting the vulva: an international electronic-Delphi consensus exercise. British Journal of Dermatology. 2013;169(2):337–343.
    1. Sanderson P, Innamaa A, Palmer J, Tidy J. Imiquimod therapy for extramammary Paget’s disease of the vulva: a viable non-surgical alternative. Journal of Obstetrics & Gynecology. 2013;33:479–483.
    1. Chan JYW, Li GKH, Chung JH, Chow VLY. Extramammary Paget’s disease: 20 years of experience in Chinese population. International Journal of Surgical Oncology. 2012;2012:5 pages.416418
    1. Anton C, Luiz AVDC, Carvalho FM, Baracat EC, Carvalho JP. Clinical treatment of vulvar Paget’s disease: a case report. Clinics. 2011;66(6):1109–1111.

Source: PubMed

3
Prenumerera